Havana, Jun 12 – About 25 volunteers, between the ages of 12 to 18, will receive next Monday the first dose of the vaccine candidate Soberana 02, as part of the beginning of the phase I / II clinical trial in pediatric ages, according to Dr. Meiby de la Caridad Rodríguez González, Director of Clinical Research at the Finlay Vaccine Institute (IFV).